Expands Medicaid coverage to include pharmacological treatment for hyperhidrosis when such treatment is ordered by a physician, registered physician assistant, or registered nurse practitioner; provides that the provisions shall not take effect unless all necessary approvals under federal law and regulation have been obtained to receive federal financial participation in the costs.
- Chamber
- Senate
- Introduced
- Jan 7, 2026
- Last action
- Apr 29, 2026 — PRINT NUMBER 8678A
- Session
- 2025-2026
- Momentum
- 45 · Moderate